Dr. James D Lyions, M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5755 Monclova Rd, Maumee, OH 43537 Phone: 419-893-2663 Fax: 419-893-7941 |
Benjamin Joseph Salpietro Jr., M.D. Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5755 Monclova Rd, Maumee, OH 43537 Phone: 419-893-2663 Fax: 419-893-7240 |
Michael John Hoeflinger, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5755 Monclova Rd, Maumee, OH 43537 Phone: 419-893-2663 Fax: 419-893-7241 |
Thomas Michael Houston, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5755 Monclova Rd, Maumee, OH 43537 Phone: 419-893-2663 Fax: 419-893-7941 |
Douglas Olson, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6005 Monclova Rd Ste 110, Maumee, OH 43537 Phone: 419-893-2663 Fax: 419-893-7941 |
News Archive
QUITPLAN® Services is bringing back the popular QuitCash Challenge, with a new twist. Now, to help tobacco users prepare for the month-long quit and win contest coming in May, several shorter practice quit challenges will be held in the coming months, starting at the State Fair.
Despite being the second most common element in the universe helium has an annoying habit of escaping into space.
Lawmakers may include a number of Medicare "fixes" in the jobs bill, now that the health overhaul bill has stalled, The Hill reports. They would include restoring Medicare provisions that expired Jan. 1 or are set to expire later this year. "Nursing homes and rehabilitation therapy providers, along with patient groups, are pushing legislation to undo a hard-dollar cap on Medicare coverage of physical, speech and occupational therapy. Hospitals are seeking to restore special payments to large rural and small urban hospitals.
Preserving good cardiovascular health during young adulthood is one of the best ways to reduce risks of premature heart attack or stroke, according to new research published today in the American Heart Association's flagship journal Circulation.
Neuralstem, Inc. announced that the final patient was treated in its Phase II trial using NSI-566 spinal cord-derived neural stem cells in the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).
› Verified 7 days ago